SCM
Schnieders Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,854
| Closed | -$270K | – | 215 |
|
|
2024
Q3 | $270K | Sell |
1,854
-67
| -3% | -$9.76K | 0.05% | 179 |
|
|
2024
Q2 | $264K | Sell |
1,921
-15
| -0.8% | -$2.06K | 0.05% | 166 |
|
|
2024
Q1 | $266K | Hold |
1,936
| – | – | 0.05% | 172 |
|
|
2023
Q4 | $263K | Sell |
1,936
-35
| -2% | -$4.76K | 0.06% | 171 |
|
|
2023
Q3 | $241K | Hold |
1,971
| – | – | 0.05% | 163 |
|
|
2023
Q2 | $250K | Hold |
1,971
| – | – | 0.05% | 171 |
|
|
2023
Q1 | $255K | Hold |
1,971
| – | – | 0.06% | 172 |
|
|
2022
Q4 | $259K | Sell |
1,971
-100
| -5% | -$13.1K | 0.06% | 176 |
|
|
2022
Q3 | $242K | Sell |
2,071
-100
| -5% | -$11.7K | 0.06% | 171 |
|
|
2022
Q2 | $255K | Buy |
2,171
+25
| +1% | +$2.94K | 0.08% | 158 |
|
|
2022
Q1 | $280K | Buy |
2,146
+771
| +56% | +$101K | 0.07% | 168 |
|
|
2021
Q4 | $210K | Buy |
1,375
+95
| +7% | +$14.5K | 0.05% | 196 |
|
|
2021
Q3 | $207K | Hold |
1,280
| – | – | 0.06% | 184 |
|
|
2021
Q2 | $210K | Sell |
1,280
-176
| -12% | -$28.9K | 0.06% | 177 |
|
|
2021
Q1 | $219K | Buy |
+1,456
| New | +$219K | 0.07% | 169 |
|
|
2020
Q1 | – | Sell |
-1,762
| Closed | -$212K | – | 160 |
|
|
2019
Q4 | $212K | Buy |
+1,762
| New | +$212K | 0.08% | 168 |
|
|
2019
Q3 | – | Sell |
-3,172
| Closed | -$346K | – | 164 |
|
|
2019
Q2 | $346K | Sell |
3,172
-220
| -6% | -$24K | 0.14% | 115 |
|
|
2019
Q1 | $379K | Sell |
3,392
-35
| -1% | -$3.91K | 0.16% | 102 |
|
|
2018
Q4 | $330K | Sell |
3,427
-568
| -14% | -$54.7K | 0.16% | 101 |
|
|
2018
Q3 | $487K | Buy |
3,995
+110
| +3% | +$13.4K | 0.2% | 97 |
|
|
2018
Q2 | $427K | Buy |
3,885
+270
| +7% | +$29.7K | 0.18% | 101 |
|
|
2018
Q1 | $386K | Sell |
3,615
-145
| -4% | -$15.5K | 0.17% | 109 |
|
|
2017
Q4 | $402K | Buy |
3,760
+2,590
| +221% | +$277K | 0.17% | 109 |
|
|
2017
Q3 | $390K | Buy |
1,170
+350
| +43% | +$117K | 0.17% | 107 |
|
|
2017
Q2 | $254K | Buy |
820
+75
| +10% | +$23.2K | 0.12% | 133 |
|
|
2017
Q1 | $218K | Buy |
+745
| New | +$218K | 0.1% | 138 |
|
|
2016
Q4 | – | Sell |
-725
| Closed | -$210K | – | 147 |
|
|
2016
Q3 | $210K | Sell |
725
-465
| -39% | -$135K | 0.12% | 130 |
|
|
2016
Q2 | $306K | Buy |
1,190
+254
| +27% | +$65.3K | 0.17% | 111 |
|
|
2016
Q1 | $244K | Buy |
+936
| New | +$244K | 0.14% | 115 |
|